SIK3 and breast carcinoma: We have currently shown that SIK3 is specifically expressed in breast cancer cells over normal breast cells, and also studies by others in ovarian cancer have confirmed SIK3 as a potential biomarker, drug target and/or tumor associated antigen, which offers further venues of research in this direction.